Most recently, a GWAS conducted in a Korean pediatric population identified CACNA2D3 (3p14.3) as a novel locus, with the lead variant showing an association with reduced risk of asthma and atopic dermatitis multimorbidity [37]. Here, CACNA2D3 is linked to atopic eczema.